An alternatively spliced p62 isoform confers resistance to chemotherapy in breast cancer. Guo Q, Wang H, Duan J, Luo W, et al. Cancer Res 2022 Aug 29. pii: 708925. doi: 10.1158/0008-5472.CAN-22-0909.

Read + Share

Amedeo Smart

Independent Medical Education

Guo Q, Wang H, Duan J, Luo W, et al. An alternatively spliced p62 isoform confers resistance to chemotherapy in breast cancer. Cancer Res 2022 Aug 29. pii: 708925. doi: 10.1158/0008-5472.CAN-22-0909.
PMID: 36041072